IL-1 and senescence: Friends and foe of EGFR neutralization and immunotherapy.

Romaniello, Donatella; Gelfo, Valerio; Pagano, Federica; Sgarzi, Michela; Morselli, Alessandra; Girone, Cinzia; Filippini, Daria Maria; D'Uva, Gabriele; Lauriola, Mattia

Romaniello, Donatella; Gelfo, Valerio; Pagano, Federica; Sgarzi, Michela; Morselli, Alessandra; Girone, Cinzia; Filippini, Daria Maria; D'Uva, Gabriele; Lauriola, Mattia.

Afiliação

Romaniello D; Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.
Gelfo V; Centre for Applied Biomedical Research (CRBA), Bologna University Hospital Authority St. Orsola -Malpighi Polyclinic, Bologna, Italy.
Pagano F; Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.
Sgarzi M; Centre for Applied Biomedical Research (CRBA), Bologna University Hospital Authority St. Orsola -Malpighi Polyclinic, Bologna, Italy.
Morselli A; Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.
Girone C; Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.
Filippini DM; Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.
D'Uva G; Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.
Lauriola M; Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.

Front Cell Dev Biol ; 10: 1083743, 2022.

Article em En | MEDLINE | ID: mdl-36712972

Palavras-chave

EGFR; IL-1; PD1 (programmed cell death protein 1); immunotherapy; moab; senescence; senotherapeutics

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Front Cell Dev Biol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália